Profile
Snehal Shah currently works at Oculis Holding AG, as President-Research & Development from 2024.
Dr. Shah also formerly worked at Noven Pharmaceuticals, Inc., as Member-Hisamitsu Group from 2012 to 2017, Kyowa Kirin Co., Ltd., as Senior Vice President-Regulatory Affairs from 2017 to 2021, and IVERIC bio, Inc., as SVP, Chief Regulatory & Product Strategy Officer.
Dr. Shah received his doctorate degree from the University of Kansas and undergraduate degree from Rutgers University- Newark.
Snehal Shah active positions
| Companies | Position | Start |
|---|---|---|
| OCULIS HOLDING AG | Chief Tech/Sci/R&D Officer | 2024-04-09 |
Former positions of Snehal Shah
| Companies | Position | End |
|---|---|---|
| KYOWA KIRIN CO., LTD. | General Counsel | 2020-12-31 |
Noven Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research, development, manufacture, marketing and sale of transdermal pharmaceutical products | Corporate Officer/Principal | 2016-12-31 |
| IVERIC BIO, INC. | General Counsel | - |
Training of Snehal Shah
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Noven Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research, development, manufacture, marketing and sale of transdermal pharmaceutical products | Commercial Services |
University of Kansas
University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IVERIC bio, Inc.
IVERIC bio, Inc. BiotechnologyHealth Technology Operates as a science-driven biopharmaceutical company that develops novel treatments for retinal diseases | Health Technology |
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals; develops biochemical reagents and other chemicals | Health Technology |
Rutgers University- Newark
Rutgers University- Newark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oculis Holding AG
Oculis Holding AG Miscellaneous Commercial ServicesCommercial Services Operates as a global biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases | Commercial Services |
- Stock Market
- Insiders
- Snehal Shah
















